Illuminating the Drug Development Path with Cell-Based Reporter Assays

In early discovery, researchers use high-throughput screening (HTS) to identify active compounds in a biologically relevant context. During lead characterization and validation, these assays generate reproducible, quantitative data to confirm activity and support candidate selection. In later stages, cell based assays are commonly used as potency assays to ensure reliability, consistency, and lot-to-lot comparability of biologics, supporting regulatory compliance. The post Illuminating the Drug Development Path with Cell-Based Reporter Assays appeared first on GEN - Genetic Engineering and Biotechnology News.